Literature DB >> 12556677

Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of the literature.

Kamran Riaz1, Alan D Forker, William L Isley, Mitchell S Hamburg, Peter A McCullough.   

Abstract

With the increasing incidence of coronary artery disease and the aging population, the prevalence of congestive heart failure (CHF) is increasing. In the majority of these cases the etiology is underlying coronary artery disease. Other less common causes of CHF include valvular heart disease, hypertension, alcoholic cardiomyopathy, and dilated cardiomyopathy. In addition, there are rare causes, one of which is hyperthyroidism. Hyperthyroidism can affect the cardiovascular system in a variety of ways. The cardiovascular manifestations range from sinus tachycardia to atrial fibrillation and from a high cardiac output state to CHF due to systolic left ventricular dysfunction. If the underlying hyperthyroidism is recognized and treated early the CHF in such cases can be cured. The authors present three cases of CHF due to systolic left ventricular dysfunction secondary to hyperthyroidism, which showed considerable improvement in the left ventricular function once the hyperthyroidism was treated. Copyright 2003 CHF, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12556677     DOI: 10.1111/j.1527-5299.2003.01124.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  17 in total

1.  B-type natriuretic peptide in patients with clinical hyperthyroidism.

Authors:  T Wei; C Zeng; Y Tian; Q Chen; L Wang
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 2.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  Thyroid hormone and heart failure.

Authors:  Ursula Maria Schmidt-Ott; Deborah Davis Ascheim
Journal:  Curr Heart Fail Rep       Date:  2006-09

4.  Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.

Authors:  Bo Hyun Kim; Kyoung Im Cho; Seong Man Kim; Nari Kim; Jin Han; Jee Yeon Kim; In Ju Kim
Journal:  Heart Vessels       Date:  2012-11-11       Impact factor: 2.037

Review 5.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 6.  Thyrotoxic cardiac disease.

Authors:  Peter Dahl; Sara Danzi; Irwin Klein
Journal:  Curr Heart Fail Rep       Date:  2008-09

7.  Heart Failure in Thyrotoxic Cardiomopathy: Extracorporeal Membrane Oxygenation Treatment for Graves' Disease.

Authors:  Joseph Allencherril; Itamar Birnbaum
Journal:  J Extra Corpor Technol       Date:  2015-12

8.  Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.

Authors:  Nathan Y Weltman; Dajun Wang; Rebecca A Redetzke; A Martin Gerdes
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 9.  Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story.

Authors:  Mohammad T Elnakish; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen
Journal:  Oxid Med Cell Longev       Date:  2015-06-04       Impact factor: 6.543

Review 10.  High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice.

Authors:  Diane Xavier de Ávila; Humberto Villacorta; Wolney de Andrade Martins; Evandro Tinoco Mesquita
Journal:  Curr Cardiol Rev       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.